Prolonged treatment-free remission in chronic myeloid leukemia patients with previous BCR-ABL1 kinase domain mutations.

Authors	Simone Claudiani, Jane F Apperley, Afzal Khan, Jamshid Khorashad, Dragana Milojkovic
Journal	Haematologica (Haematologica) Vol. 105 Issue 5 Pg. e225-e227 (05 2020) ISSN: 1592-8721 [Electronic] Italy
PMID	31537692 (Publication Type: Letter)
Chemical References	Protein Kinase Inhibitors Fusion Proteins, bcr-abl
Topics	Drug Resistance, Neoplasm (genetics) Fusion Proteins, bcr-abl (genetics) Humans Leukemia, Myelogenous, Chronic, BCR-ABL Positive (drug therapy, genetics) Mutation Protein Kinase Inhibitors (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!